Literature DB >> 8620611

Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes.

G R Li1, J Feng, Z Wang, B Fermini, S Nattel.   

Abstract

The ultrarapid delayed rectifier K+ current (IKur) in human atrial cells appears to correspond to Kv1.5 cloned channels and to play an important role in human atrial repolarization. Kv1.5 channels have consensus sites for phosphorylation by protein kinase A and C, suggesting possible modulation by adrenergic stimulation. The present study was designed to assess the adrenergic regulation of IKur in human atrial myocytes. Isoproterenol increased IKur in a concentration-dependent manner, with significant effects at concentrations as low as 10 nmol/L. The effects of isoproterenol were reversible by washout or by the addition of propranolol (1 mumol/L). Isoproterenol's effects were mimicked by the direct adenylate cyclase stimulator, forskolin, and by the membrane-permeable form of cAMP, 8-bromo cAMP. Isoproterenol had no effect on IKur when the protein kinase A inhibitor peptide, PKI(6-22)amide, was included in the pipette solution; in a separate set of experiments in which isoproterenol alone increased IKur by 45 +/- 9% relative to control, subsequent superfusion with isoproterenol in the presence of the protein kinase inhibitor H-7 failed to alter IKur. In contrast to isoproterenol, phenylephrine (in the presence of propranolol to block beta-adrenegic effects) induced a concentration-dependent inhibition of IKur, with significant effects observed at concentrations as low as 10 mumol/L. The inhibitory actions of phenylephrine were reversed by the addition of prazosin and prevented by coadministration with a highly selective inhibitor of protein kinase C, bisindolylmaleimide. These results indicate that beta-adrenergic stimulation enhances, whereas alpha-adrenergic stimulation inhibits, IKur and suggest that these actions are mediated by protein kinase A and protein kinase C, respectively. The modulation of IKur by adrenergic influences is a potentially novel control mechanism for human atrial repolarization and arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620611     DOI: 10.1161/01.res.78.5.903

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  37 in total

1.  Remodelling of human atrial K+ currents but not ion channel expression by chronic β-blockade.

Authors:  Gillian E Marshall; Julie A Russell; James O Tellez; Pardeep S Jhund; Susan Currie; John Dempster; Mark R Boyett; Kathleen A Kane; Andrew C Rankin; Antony J Workman
Journal:  Pflugers Arch       Date:  2011-12-08       Impact factor: 3.657

2.  KCNA5 gene polymorphism associate with idiopathic atrial fibrillation.

Authors:  Li Tian; Gang Liu; Le Wang; Mingqi Zheng; Yongjun Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Isoenzyme-specific regulation of cardiac Kv1.5/Kvβ1.2 ion channel complex by protein kinase C: central role of PKCβII.

Authors:  Fathima Fischer; Nadine Vonderlin; Claudia Seyler; Edgar Zitron; Sevil Korkmaz; Gábor Szabó; Dierk Thomas; Hugo A Katus; Eberhard P Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-02-28       Impact factor: 3.000

4.  Effects of diltiazem and nifedipine on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.

Authors:  Zhan Gao; Haiying Sun; Shui-Wah Chiu; Chu-Pak Lau; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

5.  Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1.

Authors:  Tao Yang; Brian F McBride; Brenda F Leake; Richard B Kim; Dan M Roden
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 6.  Modification of K+ channel-drug interactions by ancillary subunits.

Authors:  Glenna C L Bett; Randall L Rasmusson
Journal:  J Physiol       Date:  2007-12-20       Impact factor: 5.182

7.  Chronic atrial ionic remodeling by aldosterone: potentiation of L-type Ca2+ channels and its arrhythmogenic significance.

Authors:  Erick B Ríos-Pérez; Maricela García-Castañeda; Adrián Monsalvo-Villegas; Guillermo Avila
Journal:  Pflugers Arch       Date:  2016-09-15       Impact factor: 3.657

Review 8.  Is there a future for antiarrhythmic drug therapy?

Authors:  P G Guerra; M Talajic; D Roy; M Dubuc; B Thibault; S Nattel
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

9.  Noradrenaline up-regulates volume-regulated chloride current by PKA-independent cAMP/exchange protein activated by cAMP pathway in human atrial myocytes.

Authors:  Guo-Sheng Xiao; Yan-Hui Zhang; Yan Wang; Hai-Ying Sun; Clive M Baumgarten; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2018-07-08       Impact factor: 8.739

Review 10.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.